Jason E. Toombs

1.8k total citations
32 papers, 1.2k citations indexed

About

Jason E. Toombs is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jason E. Toombs has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in Jason E. Toombs's work include Phagocytosis and Immune Regulation (13 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cell death mechanisms and regulation (5 papers). Jason E. Toombs is often cited by papers focused on Phagocytosis and Immune Regulation (13 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cell death mechanisms and regulation (5 papers). Jason E. Toombs collaborates with scholars based in United States, Norway and Australia. Jason E. Toombs's co-authors include Rolf A. Brekken, Seán Dineen, Christina L. Roland, Juliet G. Carbon, D. Gomika Udugamasooriya, Kristi D. Lynn, James B. Lorens, Amanda Kirane, Michael T. Dellinger and Noah Sorrelle and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Jason E. Toombs

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason E. Toombs United States 21 554 542 395 255 130 32 1.2k
Rei Mizuno Japan 17 509 0.9× 454 0.8× 322 0.8× 303 1.2× 122 0.9× 46 1.2k
Shoichiro Tsuji Japan 13 672 1.2× 726 1.3× 418 1.1× 249 1.0× 70 0.5× 20 1.4k
Yu Rebecca Miao United States 17 601 1.1× 506 0.9× 445 1.1× 330 1.3× 232 1.8× 28 1.3k
Yun Hee Kang South Korea 18 535 1.0× 332 0.6× 258 0.7× 212 0.8× 115 0.9× 44 1.0k
Natasha M. Savage United States 18 488 0.9× 557 1.0× 585 1.5× 161 0.6× 147 1.1× 79 1.4k
Takatomo Koshiba Japan 16 658 1.2× 856 1.6× 333 0.8× 318 1.2× 99 0.8× 29 1.5k
Mang Xiao China 24 732 1.3× 343 0.6× 336 0.9× 300 1.2× 268 2.1× 59 1.6k
Slawomir Wojtowicz‐Praga United States 14 675 1.2× 738 1.4× 358 0.9× 560 2.2× 135 1.0× 20 1.6k
Simona Ruggieri Italy 20 782 1.4× 442 0.8× 310 0.8× 317 1.2× 170 1.3× 51 1.5k
David A. Leinster United Kingdom 6 383 0.7× 486 0.9× 485 1.2× 246 1.0× 68 0.5× 7 1.1k

Countries citing papers authored by Jason E. Toombs

Since Specialization
Citations

This map shows the geographic impact of Jason E. Toombs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Toombs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Toombs more than expected).

Fields of papers citing papers by Jason E. Toombs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Toombs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Toombs. The network helps show where Jason E. Toombs may publish in the future.

Co-authorship network of co-authors of Jason E. Toombs

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Toombs. A scholar is included among the top collaborators of Jason E. Toombs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Toombs. Jason E. Toombs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murimwa, Gilbert Z., Dina Alzhanova, Jill M. Westcott, et al.. (2025). SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition. Cancer Research. 85(16). 2987–2996. 2 indexed citations
2.
Huang, Xianming, et al.. (2024). Development of betabodies: The next generation of phosphatidylserine targeting agents. Journal of Biological Chemistry. 300(9). 107681–107681. 2 indexed citations
3.
Ganguly, Debolina, Marcel O. Schmidt, Noah Sorrelle, et al.. (2023). Pleiotrophin drives a prometastatic immune niche in breast cancer. The Journal of Experimental Medicine. 220(5). 8 indexed citations
4.
Chandra, Raghav, Ling Cai, Debolina Ganguly, et al.. (2022). Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment. Journal of Thoracic Oncology. 17(10). 1178–1191. 30 indexed citations
5.
Arner, Emily N., Ali A. Rizvi, Jason E. Toombs, et al.. (2021). AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Molecular Cancer Therapeutics. 21(1). 38–47. 22 indexed citations
6.
Du, Wenting, Huocong Huang, Zhaoning Wang, et al.. (2021). AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer. Molecular Cancer Research. 19(8). 1412–1421. 22 indexed citations
7.
Vijay, Rahul, Jenna J. Guthmiller, Alexandria J. Sturtz, et al.. (2021). Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation. The Journal of Experimental Medicine. 218(6). 15 indexed citations
8.
Stefanius, Karoliina, Kelly A. Servage, Marcela de Souza Santos, et al.. (2019). Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation. eLife. 8. 87 indexed citations
9.
Ludwig, Kathleen, Wenting Du, Noah Sorrelle, et al.. (2017). Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. Cancer Research. 78(1). 246–255. 119 indexed citations
10.
Wang, Miao, Mary Topalovski, Jason E. Toombs, et al.. (2015). Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Cancer Research. 75(23). 5058–5069. 36 indexed citations
11.
Kirane, Amanda, Kathleen Ludwig, Noah Sorrelle, et al.. (2015). Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. Cancer Research. 75(18). 3699–3705. 108 indexed citations
12.
Potts, Malia B., Elizabeth A. McMillan, Hyun Seok Kim, et al.. (2015). Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B. Nature Chemical Biology. 11(6). 401–408. 52 indexed citations
13.
Aguilera, Kristina Y., Lee B. Rivera, Hoon Hur, et al.. (2013). Collagen Signaling Enhances Tumor Progression after Anti-VEGF Therapy in a Murine Model of Pancreatic Ductal Adenocarcinoma. Cancer Research. 74(4). 1032–1044. 76 indexed citations
14.
Gerber, David E., Puja Gupta, Michael T. Dellinger, et al.. (2012). Stromal Platelet-Derived Growth Factor Receptor α (PDGFRα) Provides a Therapeutic Target Independent of Tumor Cell PDGFRα Expression in Lung Cancer Xenografts. Molecular Cancer Therapeutics. 11(11). 2473–2482. 35 indexed citations
15.
Kirane, Amanda, Jason E. Toombs, Jill E. Larsen, et al.. (2012). Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib. Carcinogenesis. 33(9). 1639–1646. 22 indexed citations
16.
Arnold, Shanna A., Lee B. Rivera, Juliet G. Carbon, et al.. (2012). Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation. PLoS ONE. 7(2). e31384–e31384. 62 indexed citations
17.
Dineen, Seán, Christina L. Roland, Juliet G. Carbon, et al.. (2010). Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer. Cancer Research. 70(7). 2852–2861. 86 indexed citations
18.
Sullivan, Laura A., Juliet G. Carbon, Christina L. Roland, et al.. (2010). r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction. PLoS ONE. 5(8). e12031–e12031. 37 indexed citations
19.
Roland, Christina L., Seán Dineen, Jason E. Toombs, et al.. (2010). Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts. Experimental Biology and Medicine. 235(2). 263–270. 38 indexed citations
20.
Roland, Christina L., Kristi D. Lynn, Jason E. Toombs, et al.. (2009). Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer. PLoS ONE. 4(11). e7669–e7669. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rei Mizuno Breakdown of academic impact, for papers by Shoichiro Tsuji Breakdown of academic impact, for papers by Yu Rebecca Miao Breakdown of academic impact, for papers by Yun Hee Kang Breakdown of academic impact, for papers by Natasha M. Savage Breakdown of academic impact, for papers by Takatomo Koshiba Breakdown of academic impact, for papers by Mang Xiao Breakdown of academic impact, for papers by Slawomir Wojtowicz‐Praga Breakdown of academic impact, for papers by Simona Ruggieri Breakdown of academic impact, for papers by David A. Leinster
Rankless by CCL
2026